CClinicalTrials.gg
RecruitingNCT05867290MUSASUpdated May 19, 2023

Music for Sleep After Stroke

An interventional study of Mindful music-listening with sleep hygiene in Stroke, Cardiovascular Diseases and Brain Diseases, sponsored by NHS Greater Glasgow and Clyde. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-19.

Sponsored by NHS Greater Glasgow and Clyde · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Sleep difficulties are common following stroke yet effective evidence-based interventions for improving sleep in this population are lacking. A small number of studies have investigated the use of music listening as a way to improve sleep in adults with insomnia.

This study aims to examine whether a mindful music-listening intervention can reduce subjective and objective insomnia symptoms and improve mood and fatigue post-stroke.

Six adults with a clinical diagnosis of stroke presenting with an insomnia disorder will be recruited from stroke services within NHS Greater Glasgow and Clyde. A multiple baseline single case experimental design will be employed. Participants will be randomly allocated to a baseline phase of 7, 11 or 15 days, followed by a five-week mindful music-listening intervention incorporating sleep hygiene. Changes in subjective and objective sleep will be measured using questionnaires and actigraphy, respectively. Mood and fatigue will also be measured. The data will be analysed using visual inspection, Tau-U and multi-level modelling.

02

Conditions studied

  • Stroke
  • Cardiovascular Diseases
  • Brain Diseases
  • Vascular Diseases
  • Insomnia
  • Sleep Disorder
  • Sleep Disturbance
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 6 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

NHS Greater Glasgow and Clyde is the lead sponsor of 215 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • aged 18+ (no upper age limit);
  • clinically and/or radiologically confirmed diagnosis of stroke
  • score of ≤16 on the Sleep Condition Indicator (SCI; (Espie et al, 2018))
  • at least 3-months post-stroke

Exclusion criteria

Exclusion Criteria:

  • Transient Ischemic Attack
  • subarachnoid hemorrhage
  • sleep medication commenced within the last 2 weeks (stable medication accepted)
  • significant receptive aphasia or major psychiatric/substance abuse problem preventing engagement in the intervention
  • deafness or severe hearing impairment preventing engagement in the intervention (use of hearing aids does not lead to exclusion where these support sufficient level of hearing for engagement)
  • unable to give informed consent.
  • participation in another intervention study with risk of contamination of study outcomes (determined on a case-by-case basis)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (estimated)

Study arms

  • No intervention
    Baseline Phase

    Randomly allocated baseline phase (no intervention) of 7, 11 or 15 days.

  • Experimental
    Intervention Phase

    5 week mindful-music listening intervention including sleep hygiene

    Behavioral: Mindful music-listening with sleep hygiene

Interventions

  • BehavioralMindful music-listening with sleep hygiene

    5 week intervention consisting of sleep hygiene (week 1) and daily bedtime mindful music-listening for 30 minutes or until about to fall asleep, if sooner (weeks 2-5)

06

What researchers measure

Primary outcomes

  1. Sleep onset latency (SOL)

    Time taken to fall asleep in minutes measured using actigraphy and a sleep diary completed by the participant. Higher scores indicate greater SOL.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

Secondary outcomes

  1. Total sleep time (TST)

    Total time spent asleep in bed in minutes. Measured using actigraphy and a sleep diary completed by the participant. Higher scores indicated longer time spent asleep.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

  2. Wake after sleep onset (WASO)

    Total time spent awake after sleep onset in minutes. Measured using actigraphy and a sleep diary completed by the participant. Higher scores indicate longer time spent awake.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

  3. Number of night time awakenings

    Total number of awakenings during the night. Measured using actigraphy and a sleep diary completed by the participant. Min = 0 - no Max. Lower scores indicate fewer night time awakenings.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

  4. Time in bed (TIB)

    Total time spent in bed in minutes with higher scores indicating longer time spent in bed. Measured using a sleep diary completed by the participant.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

  5. Sleep restoration

    Participant rated level of sleep restoration on awakening. Measured using a 3-point scale: refreshed, somewhat refreshed, fatigued.

    Time frame: Measured daily, from baseline to follow-up (day 1 up to day day 71).

  6. Insomnia classification

    Sleep Condition Indicator (SCI) score. Min score= 0 - Max= 32 with lower scores indicating poorer sleep.

    Time frame: Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)

  7. Daytime sleepiness

    Epworth Sleepiness Scale (ESS) score. Min score= 0 - Max= 24 with higher scores indicating greater levels of daytime sleepiness.

    Time frame: Completed at baseline, at the end of intervention (week 1 to weeks 6-8) and at follow-up (3 weeks post-intervention)

  8. Anxiety symptoms

    Generalized Anxiety Disorder Questionnaire (GAD-7) score. Min= 0 - Max= 21 with higher scores indicating more severe symptoms.

    Time frame: Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)

  9. Depressive symptoms

    Patient Health Questionnaire (PhQ-9) score. Min= 0 - Max= 27 with higher scores indicating more severe symptoms.

    Time frame: Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)

  10. Fatigue

    Fatigue Severity Scale (FSS) score. Min= 9 - Max= 63 with higher scores indicating greater fatigue severity.

    Time frame: Completed at baseline, end of intervention (week 1 to weeks 6-8 and at follow up (3 weeks post-intervention)

  11. Adherence

    Adherence to mindful music-listening as measured through music listening diary. Min= 0 - Max= 28 with higher scores indicating greater adherence.

    Time frame: Completed daily by the participant during the intervention music listening phase (weeks 3-5 to weeks 8-10)

07

Study locations

1 of 1 sites recruiting
  • Greater Glasgow and Clyde Stroke Services
    Glasgow, United Kingdom
    • Jonathan Evans, PhD · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05867290
Lead sponsor
NHS Greater Glasgow and Clyde
Collaborators
University of Glasgow, University of Edinburgh
Responsible party
Sponsor
First posted
May 19, 2023
Start date
Feb 22, 2023
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
May 19, 2023

Study contacts

Satu Baylan, PhD
Contact
s.baylan.1@research.gla.ac.uk
01412113978
Jonathan Evans, PsyD, PhD
Contact
jonathan.evans@gla.ac.uk
01412113978

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion